Correlation Between Design Therapeutics and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Travere Therapeutics, you can compare the effects of market volatilities on Design Therapeutics and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Travere Therapeutics.
Diversification Opportunities for Design Therapeutics and Travere Therapeutics
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Design and Travere is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Design Therapeutics and Travere Therapeutics
Given the investment horizon of 90 days Design Therapeutics is expected to generate 1.86 times more return on investment than Travere Therapeutics. However, Design Therapeutics is 1.86 times more volatile than Travere Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Travere Therapeutics is currently generating about 0.1 per unit of risk. If you would invest 532.00 in Design Therapeutics on September 5, 2024 and sell it today you would earn a total of 67.00 from holding Design Therapeutics or generate 12.59% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Design Therapeutics vs. Travere Therapeutics
Performance |
Timeline |
Design Therapeutics |
Travere Therapeutics |
Design Therapeutics and Travere Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Design Therapeutics and Travere Therapeutics
The main advantage of trading using opposite Design Therapeutics and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.Design Therapeutics vs. Candel Therapeutics | Design Therapeutics vs. Cingulate Warrants | Design Therapeutics vs. Unicycive Therapeutics | Design Therapeutics vs. Cardio Diagnostics Holdings |
Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |